Covenant Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Covenant Asset Management, LLC

$610 Million
Q1 2024

A detailed history of Covenant Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Covenant Asset Management, LLC holds 12,093 shares of VRTX stock, worth $5.73 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

12,093

Previous 11,294 7.07%

Holding current value

$5.73 Million

Previous $4.6 Million 9.99%

% of portfolio

0.83%

Previous 0.83%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$407.69 - $446.08 $325,744 - $356,417	799 Added 7.07%	12,093 $5.05 Million
Q4 2023 Jan 22, 2024	BUY	$343.0 - $410.68 $86,436 - $103,491	252 Added 2.28%	11,294 $4.6 Million
Q3 2023 Oct 31, 2023	SELL	$338.18 - $362.46 $3,043 - $3,262	-9 Reduced 0.08%	11,042 $3.84 Million
Q2 2023 Jul 12, 2023	SELL	$314.42 - $351.91 $5,973 - $6,686	-19 Reduced 0.17%	11,051 $3.89 Million
Q1 2023 Apr 27, 2023	BUY	$283.23 - $323.1 $114,141 - $130,209	403 Added 3.78%	11,070 $3.49 Million

Q4 2022 Jan 24, 2023	BUY	$285.76 - $321.48 $22,575 - $25,396	79 Added 0.75%	10,667 $0
Q3 2022 Nov 03, 2022	SELL	$273.83 - $305.53 $25,192 - $28,108	-92 Reduced 0.86%	10,588 $3.07 Million
Q2 2022 Jul 21, 2022	BUY	$234.96 - $292.55 $2.51 Million - $3.12 Million	10,680 New	10,680 $3.01 Million
Q2 2021 Jul 21, 2021	SELL	$187.49 - $221.1 $187,490 - $221,100	-1,000 Closed	0 $0
Q1 2021 Apr 19, 2021	SELL	$207.02 - $241.31 $3.53 Million - $4.12 Million	-17,074 Reduced 94.47%	1,000 $215,000
Q4 2020 Jan 28, 2021	BUY	$207.01 - $276.09 $63,345 - $84,483	306 Added 1.72%	18,074 $4.27 Million
Q3 2020 Oct 29, 2020	SELL	$255.65 - $303.1 $44,227 - $52,436	-173 Reduced 0.96%	17,768 $4.84 Million
Q2 2020 Jul 24, 2020	SELL	$225.48 - $295.8 $73,506 - $96,430	-326 Reduced 1.78%	17,941 $5.21 Million
Q1 2020 Apr 22, 2020	SELL	$199.77 - $247.81 $16,181 - $20,072	-81 Reduced 0.44%	18,267 $4.35 Million
Q4 2019 Jan 24, 2020	SELL	$166.71 - $223.91 $86,689 - $116,433	-520 Reduced 2.76%	18,348 $4.02 Million
Q3 2019 Oct 18, 2019	BUY	$166.23 - $187.09 $74,138 - $83,442	446 Added 2.42%	18,868 $3.2 Million
Q2 2019 Jul 17, 2019	BUY	$164.61 - $190.37 $50,535 - $58,443	307 Added 1.69%	18,422 $3.38 Million
Q1 2019 Apr 26, 2019	BUY	$163.73 - $194.7 $10,806 - $12,850	66 Added 0.37%	18,115 $3.33 Million
Q3 2018 Oct 09, 2018	SELL	$167.73 - $192.74 $81,516 - $93,671	-486 Reduced 2.62%	18,049 $3.48 Million
Q2 2018 Jul 12, 2018	BUY	$145.72 - $169.96 $211,148 - $246,272	1,449 Added 8.48%	18,535 $3.15 Million
Q1 2018 May 04, 2018	BUY	$151.6 - $177.13 $2.59 Million - $3.03 Million	17,086 New	17,086 $2.79 Million

Others Institutions Holding VRTX

# of Institutions

1,624

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Asset Management, LLC with notifications on news.

Account

Covenant Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History